Posicionamiento de la Sociedad Española de Farmacia Clínica, Familiar y Comunitaria sobre telefarmaciateleatención farmacéutica (TAF)

  1. VJ Baixauli Fernández
  2. A Molinero
  3. E Satué de Velasco
  4. J Plaza Zamora
  5. L Andraca
  6. F Mud Castelló
  7. N. Sánchez Marcos
  8. R Prats Mas
  9. S López Alaiz
  10. E Pérez Hoyos
  11. A Martín Oliveros
  12. MD Murillo Fernández
  13. MJ Sanz Orejas
Journal:
Farmacéuticos comunitarios

ISSN: 1885-8619

Year of publication: 2022

Volume: 14

Issue: 2

Pages: 5-8

Type: Article

DOI: 10.33620/FC.2173-9218.(2022/VOL14).002.02 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Farmacéuticos comunitarios

Abstract

The new information and communication technologies (ICT) have been evolving for many years, but the COVID-19 pandemic has accelerated the digital transformation of society. In the healthcare field, new activities have emerged and terms such as telemedicine, telecare and teleconsultation are becoming common. They are undoubtedly a step forward, but they risk dehumanizing the contact between healthcare providers and patients. In the pharmacy- field, Telepharmacy has emerged with undeniable logistical and commercial connotations. The preferred term of the Spanish Society of Clinical, Family and Community Pharmacy is Telepharmaceutical care (TPC) which defines it as the practice of Pharmaceutical Care using ICT in order to complement the face-to face required by the patient. TPC includes the remote provision of some community pharmacy services (CPS).

Data source: Dialnet